DISCLOSURES • Financial interests: Honoraria (Institution) : Pfizer, BMS, Ipsen, Roche, MSD, Merck, Novartis, AstraZeneca, Roche, Amgen, Astellas, Exelixis, EISAI. • ESMO, EAU, AFU - Renal Cell Carcinoma Guidelines Panel member • GETUG Board